Yuancheng Chen Selected Research

Therapeutics

6/2022	Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study.
5/2022	Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia.
2/2022	Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model.
11/2018	Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients.
3/2016	Optimal dosing regimen of biapenem in Chinese patients with lower respiratory tract infections based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation.
1/2016	Tracking Cefoperazone/Sulbactam Resistance Development In vivo in A. baumannii Isolated from a Patient with Hospital-Acquired Pneumonia by Whole-Genome Sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuancheng Chen Research Topics

Disease

14	Infections 06/2022 - 01/2016
4	Body Weight (Weight, Body) 01/2023 - 11/2020
3	Pneumonia (Pneumonitis) 01/2023 - 01/2019
3	Healthcare-Associated Pneumonia 05/2022 - 01/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 05/2022 - 03/2016
2	Epilepsy (Aura) 07/2023 - 07/2019
2	Sepsis (Septicemia) 02/2022 - 01/2021
2	Soft Tissue Infections 01/2022 - 01/2020
2	Gram-Positive Bacterial Infections 01/2021 - 01/2017
2	Meningitis 02/2017 - 11/2016
2	Neoplasms (Cancer) 08/2012 - 01/2012
1	Ulcerative Colitis 01/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2023
1	Overweight 06/2022
1	Wounds and Injuries (Trauma) 06/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2022
1	AIDS-Related Complex (ARC) 06/2022
1	Ankylosing Spondylitis 05/2022
1	Gram-Negative Bacterial Infections 01/2021
1	Invasive Candidiasis 12/2020
1	Spontaneous Abortion (Miscarriage) 11/2020
1	Hyperthyroxinemia 11/2020
1	Renal Insufficiency (Renal Failure) 11/2020
1	Familial Dysalbuminemic Hyperthyroxinemia 11/2020
1	Staphylococcal Infections 01/2017
1	Inflammation (Inflammations) 01/2013
1	Disease Progression 01/2013
1	Neutropenia 08/2012
1	Breast Neoplasms (Breast Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2016
4	Vancomycin FDA LinkGeneric 06/2022 - 11/2018
4	contezolidIBA 01/2022 - 01/2019
3	nemonoxacinIBA 01/2023 - 01/2019
3	QuinolonesIBA 01/2023 - 01/2019
3	Carbapenems (Carbapenem Antibiotics)IBA 06/2022 - 01/2019
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2022 - 01/2021
3	Oxazolidinones (2 Oxazolidone)IBA 10/2021 - 01/2019
3	Meropenem (Merrem)FDA LinkGeneric 01/2019 - 11/2016
2	DP-VPAIBA 07/2023 - 07/2019
2	Valproic Acid (Depakote)FDA LinkGeneric 07/2023 - 07/2019
2	ProdrugsIBA 07/2023 - 07/2019
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2023 - 07/2019
2	CreatinineIBA 01/2023 - 05/2022
2	Colistin (Coly-Mycin)FDA Link 06/2022 - 01/2019
2	Cefoperazone (Cefoperazone Sodium)FDA Link 05/2022 - 01/2016
2	Sulbactam FDA LinkGeneric 05/2022 - 01/2016
2	Biosimilar PharmaceuticalsIBA 05/2022 - 12/2020
2	Polymyxins (Polymyxin)IBA 02/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 11/2020
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2024
1	Monoclonal AntibodiesIBA 07/2023
1	InterleukinsIBA 07/2023
1	Capsules (Microcapsules)IBA 01/2023
1	methanesulfonic acid (methanesulfonate)IBA 06/2022
1	LactamsIBA 05/2022
1	Adalimumab (Humira)FDA Link 05/2022
1	Minocycline (Cyclops)FDA LinkGeneric 02/2022
1	TabletsIBA 01/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 11/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2020
1	Anti-Infective Agents (Microbicides)IBA 07/2020
1	Levofloxacin (Levaquin)FDA Link 07/2020
1	CoagulaseIBA 11/2018
1	levornidazoleIBA 01/2018
1	Linezolid (Zyvox)FDA Link 01/2017
1	biapenem (L 627)IBA 03/2016
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2013
1	LipopolysaccharidesIBA 01/2013
1	CytokinesIBA 01/2013
1	Gemcitabine FDA Link 08/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012

Therapy/Procedure

6	Therapeutics 06/2022 - 01/2016
2	Oral Administration 01/2020 - 01/2019
1	Topical Administration 01/2024
1	Artificial Respiration (Mechanical Ventilation) 06/2022
1	Enteral Nutrition (Feeding, Tube) 06/2022
1	Critical Care (Surgical Intensive Care) 06/2022
1	Drug Therapy (Chemotherapy) 08/2012